Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-24295
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: Position statement on exercise dosage in rheumatic and musculoskeletal diseases : the role of the IMPACT-RMD toolkit
Authors: Metsios, George S.
Brodin, Nina
Vlieland, Thea P. M. Vliet
Van den Ende, Cornelia H. M.
Stavropoulos-Kalinoglou, Antonios
Fatouros, Ioannis
van der Esch, Martin
Fenton, Sally A. M.
Tzika, Katerina
Moe, Rikke Helene
Veldhuijzen van Zanten, Jet J. C. S.
Koutedakis, Yiannis
Swinnen, Thijs Willem
Veskoukis, Aristidis S.
Boström, Carina
Kennedy, Norelee
Nikiphorou, Elena
Fragoulis, George E.
Niedermann, Karin
Kitas, George D.
et. al: No
DOI: 10.31138/mjr.32.4.378
10.21256/zhaw-24295
Published in: Mediterranean Journal of Rheumatology
Volume(Issue): 32
Issue: 4
Page(s): 378
Pages to: 385
Issue Date: Dec-2021
Publisher / Ed. Institution: Elliniki Reumatologiki Etaireia & Epaggelmatiki Enosi Reumatologon Ellados
ISSN: 2529-198X
Language: English
Subjects: Exercise; Inflammation; Inflammatory arthritis; Osteoarthritis; Physical activity; Rheumatic and muscoluskeletal disease; Rheumatoid arthritis
Subject (DDC): 615.82: Physical therapy
616.7: Diseases of musculoskeletal system and orthopaedics
Abstract: There is convincing evidence to suggest that exercise interventions can significantly improve disease-related outcomes as well as comorbidities in rheumatic and musculoskeletal diseases (RMDs). All exercise interventions should be appropriately defined by their dose, which comprises of two components: a) the FITT (frequency, intensity, time and type) and b) the training (ie, specificity, overload, progression, initial values, reversibility, and diminishing returns) principles. In the published RMD literature, exercise dosage is often misreported, which in "pharmaceutical treatment terms", this would be the equivalent of receiving the wrong medication dosage. Lack of appropriately reporting exercise dosage in RMDs, therefore, results in limited clarity on the effects of exercise interventions on different outcomes while it also hinders reproducibility, generalisability and accuracy of research findings. Based on the collective but limited current knowledge, the main purpose of the present Position Statement is to provide specific guidance for RMD researchers to help improve the reporting of exercise dosage and help advance research into this important field of investigation. We also propose the use of the IMPACT-RMD toolkit, a tool that can be used in the design and reporting phase of every trial.
URI: https://digitalcollection.zhaw.ch/handle/11475/24295
Fulltext version: Published version
License (according to publishing contract): CC BY 4.0: Attribution 4.0 International
Departement: School of Health Sciences
Organisational Unit: Institute of Physiotherapy (IPT)
Appears in collections:Publikationen Gesundheit

Files in This Item:
File Description SizeFormat 
2021_Metsios-etal_Position-Statement-IMPACT-RMD-Toolkit.pdf659.51 kBAdobe PDFThumbnail
View/Open
Show full item record
Metsios, G. S., Brodin, N., Vlieland, T. P. M. V., Van den Ende, C. H. M., Stavropoulos-Kalinoglou, A., Fatouros, I., van der Esch, M., Fenton, S. A. M., Tzika, K., Moe, R. H., Veldhuijzen van Zanten, J. J. C. S., Koutedakis, Y., Swinnen, T. W., Veskoukis, A. S., Boström, C., Kennedy, N., Nikiphorou, E., Fragoulis, G. E., Niedermann, K., & Kitas, G. D. (2021). Position statement on exercise dosage in rheumatic and musculoskeletal diseases : the role of the IMPACT-RMD toolkit. Mediterranean Journal of Rheumatology, 32(4), 378–385. https://doi.org/10.31138/mjr.32.4.378
Metsios, G.S. et al. (2021) ‘Position statement on exercise dosage in rheumatic and musculoskeletal diseases : the role of the IMPACT-RMD toolkit’, Mediterranean Journal of Rheumatology, 32(4), pp. 378–385. Available at: https://doi.org/10.31138/mjr.32.4.378.
G. S. Metsios et al., “Position statement on exercise dosage in rheumatic and musculoskeletal diseases : the role of the IMPACT-RMD toolkit,” Mediterranean Journal of Rheumatology, vol. 32, no. 4, pp. 378–385, Dec. 2021, doi: 10.31138/mjr.32.4.378.
METSIOS, George S., Nina BRODIN, Thea P. M. Vliet VLIELAND, Cornelia H. M. VAN DEN ENDE, Antonios STAVROPOULOS-KALINOGLOU, Ioannis FATOUROS, Martin VAN DER ESCH, Sally A. M. FENTON, Katerina TZIKA, Rikke Helene MOE, Jet J. C. S. VELDHUIJZEN VAN ZANTEN, Yiannis KOUTEDAKIS, Thijs Willem SWINNEN, Aristidis S. VESKOUKIS, Carina BOSTRÖM, Norelee KENNEDY, Elena NIKIPHOROU, George E. FRAGOULIS, Karin NIEDERMANN und George D. KITAS, 2021. Position statement on exercise dosage in rheumatic and musculoskeletal diseases : the role of the IMPACT-RMD toolkit. Mediterranean Journal of Rheumatology. Dezember 2021. Bd. 32, Nr. 4, S. 378–385. DOI 10.31138/mjr.32.4.378
Metsios, George S., Nina Brodin, Thea P. M. Vliet Vlieland, Cornelia H. M. Van den Ende, Antonios Stavropoulos-Kalinoglou, Ioannis Fatouros, Martin van der Esch, et al. 2021. “Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases : The Role of the IMPACT-RMD Toolkit.” Mediterranean Journal of Rheumatology 32 (4): 378–85. https://doi.org/10.31138/mjr.32.4.378.
Metsios, George S., et al. “Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases : The Role of the IMPACT-RMD Toolkit.” Mediterranean Journal of Rheumatology, vol. 32, no. 4, Dec. 2021, pp. 378–85, https://doi.org/10.31138/mjr.32.4.378.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.